Patel, S.; Shah, N.; D’Mello, B.; Lee, A.; Werstuck, G.H.
Myeloid GSK3α Deficiency Reduces Lesional Inflammation and Neovascularization during Atherosclerotic Progression. Int. J. Mol. Sci. 2024, 25, 10897.
https://doi.org/10.3390/ijms252010897
AMA Style
Patel S, Shah N, D’Mello B, Lee A, Werstuck GH.
Myeloid GSK3α Deficiency Reduces Lesional Inflammation and Neovascularization during Atherosclerotic Progression. International Journal of Molecular Sciences. 2024; 25(20):10897.
https://doi.org/10.3390/ijms252010897
Chicago/Turabian Style
Patel, Sarvatit, Nisarg Shah, Brooke D’Mello, Anson Lee, and Geoff H. Werstuck.
2024. "Myeloid GSK3α Deficiency Reduces Lesional Inflammation and Neovascularization during Atherosclerotic Progression" International Journal of Molecular Sciences 25, no. 20: 10897.
https://doi.org/10.3390/ijms252010897
APA Style
Patel, S., Shah, N., D’Mello, B., Lee, A., & Werstuck, G. H.
(2024). Myeloid GSK3α Deficiency Reduces Lesional Inflammation and Neovascularization during Atherosclerotic Progression. International Journal of Molecular Sciences, 25(20), 10897.
https://doi.org/10.3390/ijms252010897